These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2574674)

  • 1. Interaction study of fenoldopam--digoxin in congestive heart failure.
    Strocchi E; Tartagni F; Malini PL; Valtancoli G; Ambrosioni E; Pasinelli F; Riva E; Fuccella LM
    Eur J Clin Pharmacol; 1989; 37(4):395-7. PubMed ID: 2574674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study of the dopamine DA1 agonist fenoldopam in the treatment of chronic left ventricular failure due to ischaemic heart disease.
    MacDonald TM; Jeffrey RF; Muir AL; Lee MR
    Eur J Clin Pharmacol; 1990; 38(2):199-201. PubMed ID: 1970961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
    J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and the renal response to gludopa, fenoldopam and dopamine.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Oct; 30(4):652-3. PubMed ID: 1981323
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine agonists, a new perspective in cardiovascular therapy?
    Girbes AR; van Veldhuisen DJ; Smit AJ
    Neth J Med; 1991 Aug; 39(1-2):65-71. PubMed ID: 1683693
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failure.
    Blanchett DG; Green JA; Nara A; Pospisil R; Jarvis RC; Kasmer RJ; Boyle DA; Cyronak MJ; Corder CN
    Clin Pharmacol Ther; 1991 Apr; 49(4):449-56. PubMed ID: 1673097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenoldopam in dogs with spontaneous renal insufficiency.
    Brooks DP; Goldstein R; Koster PF; DePalma PD; DiCristo M; Karpinski K; Hyneck M
    Eur J Pharmacol; 1990 Aug; 184(1):195-9. PubMed ID: 1976527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.
    Schoors DF; Dupont AG
    Br J Clin Pharmacol; 1990 Oct; 30(4):651-2. PubMed ID: 1981322
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
    Clark KL; Hilditch A; Robertson MJ; Drew GM
    J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.